News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Ajax Therapeutics Receives FDA Approval for AJ1-11095 IND Application, a Novel Type II JAK2 Inhibitor, for Myelofibrosis Treatment
Tuesday, May 14, 2024Ajax Therapeutics Inc a biopharmaceutical company focused on developing nextgeneration JAK inhibitors for patients with myeloproliferative neoplasms has announced the clearance
Macomics and IFOM Announce Collaboration on Macrophage Research in Oncology
Monday, May 13, 2024Macomics Ltd a leader in macrophage drug discovery has announced a significant scientific collaboration with Prof Massimiliano Pagani from IFOM the AIRC Institute of Molecular Oncology
Arecor and Medtronic Diabetes Collaborate on Novel Thermostable Insulin for Implantable Pump Administration
Friday, May 10, 2024Arecor Therapeutics plc a biopharmaceutical company focused on advancing therapies for healthier lives has entered a research collaboration with Medtronic plc a global leader in healthcare technology
Dyno Therapeutics Partners with NVIDIA AI to Enhance Development of High-Performance Biological Sequences
Friday, May 10, 2024Dyno Therapeutics has recently announced an exciting collaboration with NVIDIA aimed at leveraging Dynos cuttingedge artificial intelligence and in vivo experimentation prowess alongside NVIDIAs
Siren Biotechnology and Catalent Announce Collaboration for Manufacturing AAV Gene Therapies Aimed at Cancer
Thursday, May 09, 2024Siren Biotechnology the pioneers behind Universal AAV ImmunoGene Therapy for Cancer have teamed up with Catalent Inc a renowned provider of advanced treatments worldwide in a strategic collaboration
Aspaveli® (pegcetacoplan) Gets Green Light in Europe for Treatment-Naïve Adult Patients with PNH
Thursday, May 09, 2024Sobi has announced that the European Commission has granted approval for an expanded indication for Aspaveli in treating adult patients with paroxysmal nocturnal haemoglobinuria who suffer
Theragent and Pluristyx Announce Collaboration to Accelerate Development of iPSC-based Therapies
Wednesday, May 08, 2024Theragent Inc a prominent Contract Development and Manufacturing Organization specializing in advancing cuttingedge cell and tissuebased therapies has announced a significant collaboration
IRLAB Embarks on Development Collaboration for IRL757, a Promising Treatment for Apathy
Wednesday, May 08, 2024IRLAB Therapeutics AB has entered into a collaboration with the McQuade Center for Strategic Research and Development LLC a part of the Otsuka pharmaceutical family
ARTBIO and Nucleus RadioPharma Team Up to Produce GMP-Grade Therapeutic Products Featuring Radioisotope Pb-212 in Support of Emerging Clinical Trials
Wednesday, May 08, 2024ARTBIO Inc a company focused on clinicalstage radiopharmaceutical development specializing
Eisbach Bio Receives FDA Clearance for IND Application of EIS-12656, a First-in-Class Allosteric Inhibitor Targeting ALC1
Tuesday, May 07, 2024Eisbach Bio GmbH a privatelyheld biotech company pioneering cancer treatment innovations has reached a significant milestone the United States Food and Drug Administration has cleared
